In addition to Treg-mediated suppression and impaired TLR signaling, DNMT3A-mutated AML cells also exhibit elevated levels of immunosuppressive cytokines such as IL-10 and TGF-β (62). The gene discussed is DNMT3A; the disease is acute myeloid leukemia.